PowerTOST and Sample size estimation for R-SABE [RSABE / ABEL]

posted by Dr_Dan  – Germany, 2014-04-18 21:29 (4456 d 00:15 ago) – Posting: # 12859
Views: 19,027

Dear Kumar Naidu
To get things clear: You are the sponsor of the study and the CRO is the service provider. If you have a reasonable sample size estimation and if you want to pay for 66 subjects then the CRO should perform the study as you suggest unless they have reasonable objections. In case you anticipate a formulation difference of <5% and a power of 80% then the sample size solely depends on the intra-subject variability. This variability is not carved in stone. It is up to you to assume if the true value is rather 42% or 34%.
At the end it is the responsibility of the sponsor.
I hope this helps.
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
392 visitors (0 registered, 392 guests [including 82 identified bots]).
Forum time: 21:44 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5